Stryker (SYK) AGM 2026 summary
Event summary combining transcript, slides, and related documents.
AGM 2026 summary
6 May, 2026Opening remarks and agenda
Meeting commenced with reminders about forward-looking statements and non-GAAP measures, and confirmation of quorum and proper notice to shareholders.
Recognition of long-serving leaders and introduction of current board members and executive team.
Shareholder proposals
Three proposals presented: election of 10 directors, ratification of Ernst & Young as auditor for 2026, and advisory vote on executive compensation.
Voting conducted online, with results announced later in the meeting.
Financial performance review
Surpassed $25 billion in sales in 2025, maintaining double-digit organic sales growth.
Category leadership across business segments, with recent creation of Ortho Tech division.
Partial view of Summaries dataset, powered by Quartr API
Latest events from Stryker
- Cyber incident disrupted Q1, but net sales rose and full-year guidance is reaffirmed.SYK
Q1 20265 May 2026 - Double-digit sales and EPS growth in 2025, with robust 2026 outlook and margin expansion.SYK
Q4 202517 Apr 2026 - Definitive additional proxy materials filed for shareholder voting, with no fee required.SYK
Proxy filing23 Mar 2026 - Virtual meeting to elect directors, ratify auditor, and approve pay amid strong 2025 results.SYK
Proxy filing23 Mar 2026 - Strategy targets digital, M&A, and margin gains, with double-digit EPS growth through 2028.SYK
Investor Day 20253 Feb 2026 - Q2 organic sales up 9%, adjusted EPS up 10.6%, and guidance raised on strong demand.SYK
Q2 20242 Feb 2026 - Mako innovation, easing pricing, and new launches drive growth and share gains into 2025.SYK
2024 Wells Fargo Healthcare Conference22 Jan 2026 - Q3 net sales up 11.9% and adjusted EPS up 16.7%, with strong 2024 outlook and M&A momentum.SYK
Q3 202418 Jan 2026 - Double-digit organic growth and margin expansion, with portfolio moves and Spine impairments.SYK
Q4 20249 Jan 2026